Abstract
Obstructive sleep apnea (OSA) is a common heritable disorder displaying marked sexual dimorphism in disease prevalence and progression. Previous genetic association studies have identified a few genetic loci associated with OSA and related quantitative traits, but they have only focused on single ethnic groups, and a large proportion of the heritability remains unexplained. The apnea-hypopnea index (AHI) is a commonly used quantitative measure characterizing OSA severity. Because OSA differs by sex, and the pathophysiology of obstructive events differ in rapid eye movement (REM) and non-REM (NREM) sleep, we hypothesized that additional genetic association signals would be identified by analyzing the NREM/REM-specific AHI and by conducting sexspecific analyses in multiethnic samples. We performed genomewide association tests for up to 19,733 participants of African, Asian, European, and Hispanic/Latino American ancestry in 7 studies. We identified rs12936587 on chromosome 17 as a possible quantitative trait locus for NREM AHI in men (N = 6,737; P = 1.7 3 10 28 ) but not in women (P = 0.77). The association with NREM AHI was replicated in a physiological research study (N = 67; P = 0.047). This locus overlapping the RAI1 gene and encompassing genes PEMT1, SREBF1, and RASD1 was previously reported to be associated with coronary artery disease, lipid metabolism, and implicated in Potocki-Lupski syndrome and Smith-Magenis syndrome, which are characterized by abnormal sleep phenotypes. We also identified gene-by-sex interactions in suggestive association regions, suggesting that genetic variants for AHI appear to vary by sex, consistent with the clinical observations of strong sexual dimorphism.
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Clinical Relevance
We identified an association with apnea-hypopnea index during non-rapid eye movement sleep in men in a region that includes a strong biological candidate gene, but not in women. Biological pathways involved in the etiology of obstructive sleep apnea are likely different in men and women, and understanding sex-specific genetic associations may yield novel insights into the pathogenesis of this complex condition.
Obstructive sleep apnea (OSA) is a complex chronic condition that affects more than 10% of the population, and is associated with cardiometabolic and behavioral morbidity (1) (2) (3) . The prevalence of OSA is particularly high in minority racial/ethnic groups, such as those with African, Asian, and Hispanic ancestry (4) (5) (6) (7) . Moreover, OSA is approximately threefold more prevalent in men as compared with women (8) . In women, OSA severity is less likely to worsen in the supine compared with other sleeping positions (9) , and more likely to worsen in rapid eye movement (REM) sleep, when neuromuscular tone and chemoreflexes are reduced (9, 10) . These differences have been attributed to sex differences in airway collapsibility, related to both differences in anatomy and respiratory chemosensitivity (11) . An increase in OSA severity in women after menopause also suggests a role for sex hormones in influencing this disorder (12) .
The severity of OSA is most often characterized by the apnea-hypopnea index (AHI), defined as the number of apnea and hypopnea events per hour of sleep. AHI levels are highly heritable in African Americans and European Americans, with 30%-40% of the variance explained by genetic factors (13, 14) . Previous genetic studies have identified several genetic variants associated with AHI, although these findings were based on modest sample sizes or single ethnic groups, and largely have not been replicated across populations (15) (16) (17) (18) .
Large-scale genome-wide association studies (GWAS) have identified sexual dimorphism in genetic loci for traits associated with OSA, such as body fat distribution, particularly waist circumference and waist-to-hip ratio, each adjusted for body mass index (BMI) (19, 20) . Furthermore, measures of adiposity, such as waist phenotypes, have been shown to be regulated by sexually dimorphic genes (19, 21) . Animal models suggest that both gonadal hormones and X chromosome dose influence lipid levels (22) . Despite strong clinical and epidemiological evidence for sex differences in OSA, prior genetic association studies were not sufficiently powered to study consistent sex differences in OSA in multiethnic samples (15) (16) (17) .
We conducted GWAS in multiethnic samples from seven cohorts to identify genetic variants with sex-specific association for AHI. Given differences in the physiological bases for OSA in REM and non-REM (NREM) sleep (23), we performed analyses for AHI calculated for each sleep state (REM, NREM). Although BMI is a significant risk factor for OSA, only 40% of the genetic variance for OSA is shared with BMI (14) . Therefore, we adjusted for BMI to discover genetic loci acting independently of BMI, which may provide insights into novel etiological mechanisms. We focused on association signals that show concordant direction of effects across African, Asian, Hispanic/Latino, and European Americans through BMI-independent pathways.
Methods

Study Subjects
We included seven cohorts in the discovery analyses: the ARIC (Atherosclerosis Risk in Communities Study; n = 1,463 European Americans), the CFS (Cleveland Family This work was supported by National Institutes of Health (NIH) grants R01-HL113338, P01-CA134294, and R35-CA197449 (H.C.), T32-HL007901 and R01-HL113338 (B.E.C.), and R01-HL113338 and R35-HL135818 (S.R.). The Sleep Reading Center of Brigham and Women's Hospital was supported by NIH grants 5-R01-HL046380-15 and 5-KL2-RR024990-05; the Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C; the Framingham Heart Study is conducted and supported by NHLBI in collaboration with Boston University contract N01-HC-25195; funding for SHARe Affymetrix genotyping was provided by NHLBI contract N02-HL-64278; SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University; funding support for the Framingham Sleep Heart Health Study was provided by NIH/NHLBI grant U01 HL 53941; the baseline examination of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) was carried out as a collaborative study supported by contracts from the NHLBI to the University of North Carolina Table 1 ). An additional six cohort studies and data from one physiological research study were analyzed to examine for generalizability across samples. Details about the study subjects are provided in the data supplement.
Phenotypes and Covariates
OSA was quantified using the AHI, defined as the number of episodes of complete (apnea) or partial (hypopnea) cessations of airflow per hour of sleep (or recording time). In this study, sleep data from all seven discovery studies were scored in our Sleep Reading Center. Details of the sleep testing and scoring procedures for each cohort are provided in the data supplement. The primary phenotype was the AHI calculated across the total sleep (or recording) period (AHI-total; AHI-T). All studies used a hypopnea definition that required a 3% or greater event-related desaturation. Covariates include age, sex, and BMI. AHI measured during REM (AHI-R) and NREM (AHI-N) sleep periods also were analyzed where available (ARIC, CFS, FHS, MESA, and MrOS).
Genotyping and Quality Control
Study participants in ARIC, MESA, and Starr were genotyped using the Affymetrix 6.0 array; CFS participants were genotyped using the Illumina OmniExpress, Affymetrix 6.0, and the ITMAT-BroadCARe (IBC) (24) arrays; FHS participants were genotyped using the Affymetrix 500K mapping array and Illumina Omni5 array; HCHS/SOL participants were genotyped using the Illumina Omni 2.5M array with custom content; and MrOS participants were genotyped using the Illumina Omni 1M array. Data from CFS, FHS, MESA, MrOS, and Starr were phased using SHAPEIT (25) and imputed using IMPUTE2 (26) , and a 1000 Genomes Project phase 3 background (version 5; all populations, which contains haplotypes on 2,504 samples for a total of approximately 81.2 million polymorphic markers); ARIC and HCHS/SOL were imputed using a 1000 Genomes Project phase 1 background. SNP strands were checked in Ensembl and with 1000 Genomes data in SHAPEIT. SNPs with an IMPUTE2 Info score less than 0.88, or a minor allele frequency less than 1% in each study cohort, were excluded from analyses.
Statistical Analysis
Rank-normalized age and sex-adjusted residuals were analyzed using linear mixed models with a genetic relatedness matrix in GEMMA (27) to control for population stratification and relatedness, adjusting for BMI and BMI 2 . Multiethnic meta-analyses were performed using the inverse variance-weighted fixed-effects approach in METAL (28) . Details on statistical analyses are provided in the data supplement.
Results
Demographics
Key characteristics of each cohort are presented in Table 1 , with additional details in the data supplement. Across the seven distinct cohorts, data were available for 19,733 individuals, including 10,113 women. Participants were, on average, middle-aged to elderly, and were overweight to obese. The proportion with moderate to severe sleep apnea (AHI > 15 events/h) ranged from 11.7% to 54.8%. In general, the AHI varied with the mean age of the cohort (higher in the older cohorts). Overall, the sample ancestry was 29.0% European, 6.2% African, 63.6% Hispanic, and 1.2% Asian.
Sex-combined and Sex-stratified Analyses
The top results of the multiethnic metaanalyses are shown in Table 2 . In sexcombined results, eight loci showed suggestive association (P , 1.0 3 10 26 ) with AHI-T, five loci with AHI-N, and two loci with AHI-R. These regions included rs146579140, where variation was associated with AHI-N at an almost significant level (P = 8.8 3 10 28 ). In sexstratified results, 6 loci showed suggestive association with AHI-T, 3 loci with AHI-N, and 3 loci with AHI-R in women; 11 loci showed suggestive association with AHI-T, 3 loci with AHI-N, and 2 loci with AHI-R in men. In addition, there was one locus significantly associated with AHI-N in men on chromosome 17 (Figure 1) , with a lead SNP rs12936587 (P = 1.7 3 10 28 ). This locus overlapped with the gene, RAI1 (Figure 1C ), which codes retinoic acid induced 1 that has been implicated in Smith-Magenis syndrome (SMS) (29) . This lead SNP also showed suggestive association with AHI-N in sex-combined analysis, although the findings reflected associations in men and not women. Figure 2 shows that, compared with men with a homozygous genotype of the ancestral allele (A), men with more risk alleles (G) had a higher age-and BMIadjusted AHI-N on average, but there was no such pattern in women.
Gene-by-Sex Interaction
We performed gene-by-sex interaction analyses for top loci in Table 2 and identified 13 gene-by-sex interactions in multiethnic meta-analyses, after Bonferroni correction to control for a family-wise significance level of 0.05. Of these 13 geneby-sex interactions, 12 had significant or suggestive association in men, but not in women (including rs12936587 with AHI-N; interaction P = 2.6 3 10 25 ), and one had suggestive association in sex-combined results, but neither in men nor in women (although the P value in men was still several orders of magnitude lower than in women). These results suggest that there might be different genetic mechanisms for OSA in women and men.
Expression Quantitative Trait Loci Databases
We examined our most significant SNPs in the RAI1 region (National Center for Biotechnology Information build 37 locations: chr17:17531709-17644364; P , 1 3 10 27 ) in expression quantitative trait loci (eQTLs) databases that associate SNPs with gene expression in specific cell lines and tissues (see Table E1 in the data supplement). Five of the eight genes associated with the RAI1 locus SNPs had a minimum eQTL P value less than 1 3 10 26 : PEMT (whole-blood P = 2.1 3 10 220 ), SREBF1 (whole-blood P = 5.0 3 10 220 ), RASD1 (monocyte P = 6.8 3 10 212 ), RAI1 (lymphoblastoid P = 3.4 3 10 27 ), and TOM1L2 (pituitary P = 9.4 3 10 27 ). 
Assessment of Generalizability in Independent Samples
In summary data provided by replication cohort studies (Table E2) , we found no evidence for association with AHI-N for RAI1 in men (P = 0.34). However, a consistent direction of association was found in the CHS (Cardiovascular Health Study), the only replication cohort in which sleep studies were scored by the same sleep reading center that scored data in the discovery cohorts.
We replicated the association with rs12936587 in an independent physiological research study of 67 individuals (70% male; Table E3 ) studied with in-laboratory polysomnography for the purposes of elucidating the physiology of OSA. Details about the study subjects are provided in the data supplement. The sample included 55 patients with moderate to severe OSA without other significant comorbidities and 12 healthy control subjects. In this well-phenotyped sample, after adjusting for age, sex, and BMI, the risk G allele of rs12936587 was associated with increasing AHI-N (P = 0.047). The association was stronger when we restricted the analysis to AHI-N in the supine position (P = 0.017), when airway collapsibility is high.
Discussion
To our knowledge, this is the largest genome-wide analysis of AHI and the only multiethnic sex-specific AHI meta-analysis to date. It is also the first human genetic epidemiological study that has examined AHI-R and AHI-N. Analyses of rigorously collected quantitative sleep data and genome-wide genotype data identified several novel genetic regions with at least suggestive association evidence with each AHI measure. The most significant findings emerged from sex-specific and sleep state-specific analyses. Across all cohorts and race/ethnic groups, the most significant finding was for an association between a locus in RAI1 in men for AHI-N sleep. Our results identify several biologically plausible candidates for future functional studies, and highlight genetic variants that may specifically influence OSA propensity in REM versus NREM sleep, which may have different associations in men and women. The finding of multiple significant gene-by-sex interactions further provides statistical evidence of distinct genetic mechanisms influencing OSA in men and women. RAI1 is a promising candidate gene for OSA. It encodes a protein that is highly expressed in neuronal tissues and is involved in early neural differentiation and transcriptional regulation of circadian clock components. Haploinsufficiency of the RAI1 gene has been implicated in SMS (29) , a complex neurobehavioral disorder that is characterized by multiple craniofacial abnormalities, sleep disturbances, and obesity (30) . The craniofacial features include a brachycephalic head form and midface hypoplasia, which are anatomic risk factors for OSA (30, 31) . A majority of individuals with SMS have significant sleep difficulties and disturbed sleep architecture and circadian rhythms (32) , and excessive daytime sleepiness. Speech abnormalities, a hoarse voice, and airway hypotonia are also reported (33) , suggesting a role of RAI1 in influencing upper airway function. Abnormalities in RAI1 also have been implicated in Potocki-Lupski syndrome (PTLS) (34) (35) (36) . Patients with PTLS often have developmental delay and mild dysmorphic facial features (34, 35) , and can exhibit multiple neurological and cardiovascular abnormalities. Eight of the nine patients with PTLS in the initial study displayed central and/or OSA (36) . Both SMS and PTLS appear to involve the RAI1 gene on the short arm of chromosome 17 (37) . A de novo RAI1 mutation has been reported in a boy with rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation. The individual displayed an AHI of 10 at age 5 years and 27 at age 8 years, hypercholesterolemia, and macrocephaly (38) . In mice, Rai1 haploinsufficiency is associated with hyperphagia and obesity and abnormal expression of multiple genes in the hypothalamus, including BNDF (associated with behavioral and psychiatric morbidities) and WNT9B (associated with midfacial development) (39) . Although the authors suggested the value in further investigating the role of RAI1 in growth, adiposity and behavior, our results also suggest value in considering sleep apnea as a relevant RAI1 phenotype.
RAI1 and other genes in the locus may be involved in OSA etiology. Multiple SNPs in the locus overlap epigenetic and/or eQTLs evidence that may indicate regulatory effects. The SNP rs12938840 (P = 3.97 3 10 27 ) overlaps enhancer regions in 127 Roadmap Epigenomics and ENCODE cell lines, and in a further 129 samples of brain regions (40) (41) (42) (43) . Lead SNPs are associated with expression of five genes (minimum eQTL P , 1 3 10 26 ; Table E1 ), including PEMT, SREBF1, RAI1, RASD1, and TOM1L2 (44) (45) (46) (47) . SREBF1 (formerly SREBP1), an important cholesterol biosynthesis regulator, is activated in mice subjected to intermittent hypoxia, leading to hyperlipidemia (48) . Activation of Srebf1 in mouse type 2 alveolar cells leads to lipotoxicity, chronic pulmonary inflammation, and alveolar remodeling (49) . Pemt, also involved with lipid metabolism, displays sex-specific effects in regulation of high-density lipoproteins and very-low-density lipoproteins in mice (50) . A waist:hip ratio GWAS association with rs4646404 at the PEMT locus was largely sex specific (21) . RAI1 and RASD1 (formerly DEXRAS1) regulate circadian rhythm (32, 51, 52) . Rai1 haploinsufficiency in mice leads to sexspecific differences in subcutaneous and abdominal fat distributions (39) . The lead SNP rs12936587 (RAI1) is also significantly associated with coronary artery disease. A sex-stratified analysis indicated that this result was almost entirely due to an association in men (53) , providing an exciting avenue for investigating sex differences in not only OSA, but also in the association between OSA with coronary artery disease (reported to be stronger in men compared with women) (2). These results also support the importance of future assessment of pleiotropy, specifically the influence of genetic variants that influence both OSA and cardiometabolic disease and other co-occurring traits.
There are several possible explanations for stronger associations between the RAI1 locus and AHI-N in men compared with women. Men are more likely to have a higher AHI-N than women (9), which has been attributed to poorer neuromuscular compensatory mechanisms. Thus, genetic variants that further reduce airway patency or ventilatory stability in sleep may have stronger effects in men due to underlying anatomic or physiological risk factors. Conversely, factors that protect women in NREM sleep from recurrent apneas, such as sex hormone-mediated modulation of respiratory chemosensitivity in NREM sleep, may attenuate effects of some genetic variants. It is also possible that sex steroids interact with genetic variants in RAI1 to differentially affect the development of the brain or craniofacial structures, or otherwise interact with genes regulated by sex hormones. RAI1 is up-regulated by retinoic acid, which can interact with sex steroids. In the western mosquitofish, Gambusia affinis, retinoic acid controls sex-specific development of motor neurons within the spinal cord (54) . Furthermore, it has been reported that male Rai1-transgenic mice are more growth retarded than are female transgenic mice (55) . Rai1 haploinsufficiency in mice leads to sex-specific differences in adiposity, with greater abdominal fat in females compared with males (39) .
This study has several strengths, including the rigorous phenotyping for all discovery cohorts by a central sleep reading center of the sleep studies to ensure high degrees of quality control. Participants in five of the seven cohorts were studied using almost identical equipment and scoring techniques. Consistency of findings for our most significant finding was observed across the five distinct discovery cohorts with available data on AHI-N, as well as across all ethnic/racial groups, even when using data from alternative sleep apnea testing devices. The inclusion of multiple ethnic/race groups allowed leveraging different linkage disequilibrium structures across populations to identify genetic variants consistently associated with the phenotypes across multiple ethnic/race groups. Genome-wide genotype data were available for the largest sample with OSA phenotypes to date.
The AHI was defined using standard approaches that are used commonly, are reproducible, and show heritability. Hypopneas minimally required a 3% or greater oxyhemoglobin desaturation. Although AHI levels are highly correlated regardless of hypopnea definition (56) , it is possible that associations may have varied because of use of different measurement approaches. The strongest findings for the AHI-N may not only reflect the specificity of this phenotype, but also the greater accuracy of AHI measures scored from polysomnograms that include electroencephalography recording. The power for replication was limited due to modest sample size (particularly for stage-specific results), although associations in the CHS European Americans, which had undergone identical phenotyping as several of the discovery cohorts, provided evidence consistent with the discovery finding in the RAI1 region. In addition, in an independent inlaboratory physiological research study of carefully phenotyped individuals that explicitly recruited known cases of OSA without other significant comorbidities, the association with AHI-N in the RAI1 region was replicated in sex-combined analysis. This sample, however, was too small to test for sex-specific differences in associations. Although this observation needs to be cautiously interpreted, it is of interest that the strongest finding was for AHI-N sleep in the supine position. Men have a significantly higher proportion of apneas in NREM sleep than women, likely due to the occurrence of greater breathing instability in NREM sleep in men compared with women. Men also have more severe sleep apnea in the supine compared with the nonsupine position, attributed to the effects of positional-dependent airway collapsibility. In contrast, women show a REM-predominant pattern and less positional dependency (57) . In other words, the lead SNP associated most strongly with a phenotype subtype most characteristic of "male" sleep apnea. The lack of significant association for this phenotype in our sex-combined discovery sample may reflect differences in the spectrum of sleep apnea in the physiological study compared with the predominant community-based samples, where sleep apnea in women tends to be mild.
Our study, although identifying novel genetic pathways that may influence OSA, was not designed to identify specific mechanisms. In particular, we were not able to assess the extent to which the genetic associations with AHI could be explained by craniofacial features, differences in body fat distribution (particularly neck circumference), or physiological traits due to lack of information on specific intermediate phenotypes in most of the study samples.
In conclusion, we have identified from multiethnic meta-analyses several interesting biological candidates for sex-specific and sleep state-specific associations with AHI, the most widely used clinical measure for OSA. The approach underscores the value of sexspecific analyses in a trait, such as OSA, for which there are significant differences in presentation and pathogenesis between men and women. It is widely recognized that the overall AHI likely reflects a heterogeneous set of phenotypes. The analysis of sleep state-specific (REM, NREM) findings allowed assessment of more specific OSA phenotypes (i.e., operating in the background of different levels of neuromuscular control) than the overall AHI. Further investigation of the RAI1 regional association is particularly promising given its role in at least three congenital syndromes associated with sleep abnormalities and its influence on metabolic and physiological traits closely associated with OSA. However, future large-scale studies are warranted for replication and refinement of signals. These studies could lead to important insights into the underlying pathogenesis of the disorder, resulting in targeted treatments, as well as inform screening and risk stratification. Additional insights into the genetic bases for OSA may be gleaned from further detailed phenotyping, including assessments of neuromuscular control of the airway. n
